Home  >  Products  >  LRG1 (leucine-rich alpha-2-glycoprotein 1) Blocking Peptide (the N terminal of LRG1)(100ug)
LRG1 (leucine-rich alpha-2-glycoprotein 1) Blocking Peptide (the N terminal of LRG1)(100ug)

LRG1 (leucine-rich alpha-2-glycoprotein 1) Blocking Peptide (the N terminal of LRG1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LRG1 Antibody(ARP52475_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP52475
Size: 100ug
Weight: 38kDa
Gene: 116844
Format: Lyophilized powder
Target: The leucine-rich repeat (LRR) family of proteins, including LRG1, have been shown to be involved in protein-protein interaction, signal transduction, and cell adhesion and development. LRG1 is expressed during granulocyte differentiation (O'Donnell et al., 2002 [PubMed 12223515]).
Alternative names: HMFT1766; LRG
See Full Product Listings >